Seraxis
Pre-clinicalA biotechnology company developing cell replacement therapies for diabetes using stem cell-derived pancreatic islet cells.
Founded
2009
Focus
Cell & Gene Therapy
About
A biotechnology company developing cell replacement therapies for diabetes using stem cell-derived pancreatic islet cells.
Funding History
3Total raised: $18M
Grant$5MNational Institutes of HealthJun 15, 2020
Series A$10MUndisclosedJun 15, 2017
Seed$3MJuvenile Diabetes Research FoundationJun 15, 2014
Company Info
TypePrivate
Founded2009
LocationGermantown, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile